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Abstract 
        In order to better comprehend onset and progression of diseases such as cancer, the 
means by which genes are regulated must be understood.  RNA Polymerase II (Pol II) transcribes 
mRNAs that are translated into proteins, but this process is tightly controlled by transcription 
factors that recruit Pol II to promoter elements.  These transcription factors determine if and 
when a gene is expressed at a basal level.  This thesis focuses on the NFAT and AP-1 family of 
transcription activators.  Each of these families has been characterized as important 
transcriptional activators in the onset and growth of cancer, but their mechanism of action is not 
well understood.  
        Genes up-regulated in mammary duct carcinoma in response to the environmental 
carcinogen cadmium chloride were identified.  These genes where then used to determine the 
optimal cadmium concentration and time of treatment for maximal transcriptional 
induction.  ChIP assays against NFATc2 and cJun were performed before and after treatment 
with cadmium.  ChIP and qRT-PCR data collected suggests that genes MMP-1 and RAB11 are 
upregulated via cadmium chloride exposure and transcription factors NFATc2 and AP-1 are 
bound to promoter elements of each of these genes.  
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Introduction: 
An Overview of Transcription 
        Transcription is the process by which cells use template DNA to make RNA, which 
codes for specific proteins.  DNA is conserved throughout all cells and contains coding 
information needed to produce a vast library of over 20,000 proteins1,2.  Every cell type does not 
need each of these proteins and tight regulation must occur from cell to cell in order to produce 
only necessary proteins.  For example, cytotoxic T cells need to produce cytotoxins in order to 
kill infected cells, while neural cells must produce neurotransmitters important in cell-to-cell 
communication.  Thus, each of these cell types must have mechanisms in-between DNA and 
RNA production to control expression of one gene over another.  Understanding mechanisms 
vital to RNA transcriptional regulation of genomic information is fundamental for further 
improving treatments to diseases.  
        At the core of transcription is the enzyme RNA Polymerase II  (Pol II) and associated 
general transcription factors.  Transcription occurs when Pol II adds complementary nucleotide 
triphosphates (NTPs) together via phosphodiester bonding catalyzed in the active site of Poll 
II.  This reaction is facilitated by the high-energy bonds between the three phosphate groups 
attached to each nitrogenous base in NTPs.  As NTPs are incorporated into a strand, a nascent 
RNA product is formed3.  Nascent RNA products are produced with high fidelity due to 
hydrogen bonding with template DNA and proofreading activity associated with Pol II4,5. 
When studying Pol II it is important to understand its tertiary structure and the effect this 
structure has on Pol II’s enzymatic activity.  Poll II is comprised of 12 protein  
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Figure 1: Schematic of PIC formation.  PIC begins with TBP domain of TFIID binding to the -30 
nucleotide TATA box upstream of the first exon (red rectangle) and transcription start site.  TFIID 
recruits TFIIB, TFIIE, and TFIIH.  TFIIH helicase activity opens up dsDNA for transcription to begin18.   
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subunits (RPB1 - RPB12).  Together these subunits make four domains within the Pol II enzyme: 
the active site that binds DNA for template mediated synthesis, a clamp to keep DNA in the 
active site, a funnel for NTP incorporation, and a “rudder” which removes the complementary 
RNA strand from template DNA1,6.  Each of these domains is used in the three steps of 
transcription, which are initiation, elongation, and termination. 
        Initiation is the first part of RNA transcription and involves targeting Pol II to 
transcription start sites throughout the genome.  Pol II can synthesis RNA, but alone is incapable 
of targeting protein-coding genes within DNA and needs help being recruited to promoter 
elements via general transcription factors.  Pol II associates with general transcription factors in 
order to utilize their ability to bind to specific promoter elements upstream of protein coding 
genes.  As well, one of the general transcription factors provides helicase activity that opens up 
double stranded DNA so that Pol II can begin transcription2,7. 
        When Pol II associates with general transcription factors on promoter DNA, a 
preinitiation complex (PIC) forms (Figure 1).  PIC formation starts with the TATA binding 
protein (TBP) subunit of TFIID binding the TATA box which is 30 basepairs upstream of the 
transcription start site.  Although TBP is a common factor for recruitment of general 
transcription factors, other transcription factors can facilitate an analogous function. Upon TBP 
binding to DNA, two “kinks” are created in the DNA which assist in Poll II association8.  TFIIB 
then targets DNA into the active site of Pol II with the aid of TFIIF.  Finally, TFIIE and TFIIH 
are recruited the TFIIH helicase activity unwinds the double stranded DNA in order for Pol II to 
access the template strand9.  Often, once Pol II has access to the template strand, it is held in a 
paused stage where small transcripts are produced.  Once the PIC is able to escape pausing it 
enters the elongation stage in which complementary RNA is produced.  Upon elongation most 
PIC proteins dissociate and initiation is ready to start elsewhere on the genome10,11. 
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Regulatory Elements in Eukaryotes 
Understanding the organization of promoters is essential to understanding regulation of 
RNA transcription. Promoters are elements within genomic DNA that are upstream of 
transcription start sites where transcription factors can bind. Transcription factor is a generic 
term for a set of proteins that bind DNA and regulate transcription14. Regulation can be achieved 
through recruitment of general transcription factors, interaction with PIC and looped bridging of 
mediator molecules to stabilize transcription complexes15,16.  Transcription factors can be thought 
of as acting alone, but their ability to act cooperatively gives rise to a larger diversity of 
transcriptional regulation.  A set of three factors could form many different homo and hetero 
dimers in order to regulate transcription of different genes or levels of a single gene17. 
There are three general categories of promoter elements; core promoter elements, 
proximal regulatory elements, and distal enhancer elements12.  The core promoter elements 
consist of a TATA-box for TBP association and PIC recruitment via TFIID (Figure 1).  Also 
core promoter elements consist of BRE elements that TFIIB binds to and aligns Pol II with the 
transcription start site9.  Positioned within a few hundred bases of the core promoters are the 
proximal regulatory elements.  Proximal regulatory elements allow for transcription factor 
binding to act in a repressive or activating manner (Figure 2).  Distal enhancer elements are 
positioned up to thousands of bases away from transcription start site and also bind transcription 
factors in a repressive or activating  
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Figure 2: Schematic of regulatory elements.  Transcription factors can bind to DNA at proximal 
and distal sites.  Proximal promoters are within a couple hundred bases and bind transcription 
factors that interact with PIC formation.  Distal enhancers are located thousands of bases away 
and bind transcription factors.  These factors interact by looping DNA and interacting with 
mediators (grey circles)18. 
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manner.  The position of distal enhancers has been documented as irrelevant because relocation 
of these distal enhancers has shown not to affect transcription.  Distal enhancers function by 
binding transcription factors and looping DNA to allow stabilization of transcription machinery 
(Figure 2). 
AP-1 Family Transcription Factors  
Notable among the transcription factors are members of the Activator Protein 1 (AP-1) 
family.  The AP-1 family of transcription factors are composed of dimers of two alpha helical 
proteins.   More specifically AP-1 dimers can be characterized as basic leucine zippers, each of 
which contains a stretch of five hydrophobic leucines on one side of an alpha helix (Figure 
3).  Past the five leucine residues, the alpha helixes diverge and the basic regions bind to 
DNA18.  Upon binding to DNA the affinity of dimerization increases between each pair of AP-1 
family members which helps facilitate DNA binding.  AP-1 has been characterized to bind to 
TRE elements within proximal promoters of DNA and facilitate transcription specific to genes 
containing TRE elements19.  
        The AP-1 family is made of four smaller families of proteins: Jun, Fos, ATF, and 
MAF.  Among these smaller families, members of the Jun family are able to form homodimers 
as well as heterodimers with the other family members.  In contrast, Fos members can only form 
heterodimers with members of other families and lack the ability to form homodimers20.  The 
AP-1 family of transcription factors become phosphorylated in response to external and internal 
stimuli and play a vital role in regulating the transcription of genes that encode proteins vital to 
differentiation, proliferation, and apoptosis21.  The mechanism of AP-1 phosphorylation is 
through the mitogen-activated protein kinase (MAPK) which activates the Jun N-terminal kinase 
(JNK) and causes  
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Figure 3: AP-1 Structure.  AP-1 is a basic leucine zipper DNA binding protein.  DNA is shown 
in grey.  A heterodimer above is shown binding to DNA and contains cFos (red) and cJun (blue).  
Electrostatic interactions between the hydrophobic leucine residues are depicted in orange.  
Glover, J. N., and Harrison, S. C. Crystal structure of the heterodimeric bZIP transcription factor 
cFos-cJun bound to DNA, Nature 373, 257-261 (1995). 
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phosphorylation of AP-1 family proteins.  Once phosphorylated, AP-1 protein characteristics are 
altered and they become more active transcription factors22,23.   
NFAT Family Transcription Factors 
The nuclear factor of activated T cells (NFAT) is another family proteins that act as 
transcriptional activators.  Typically NFAT family proteins are phosphorylated and localized to 
the cytosol in an inactive form that cannot bind DNA and activate transcription.  Environmental 
conditions can cause an increase in cytosolic calcium concentration, which activates a calcium 
binding protein (calmodulin) and a calcium dependent phosphatase (calcineurin) (Figure 
4A).  Activation of both of these proteins leads to cleavage of phosphate groups from NFAT 
family members revealing their nuclear localization sequence, which induces relocalization to 
the nucleus24.  This process is reversed by tyrosine phosphorylation regulated kinase 2, which re-
phosphorylates NFAT family members targeting them for nuclear export25.  Figure 4 shows 
DNA binding domains as well as phosphorylation domains within two of the most characterized 
NFAT family members: NFATc1 and NFATc2. This Thesis focuses specifically on NFATc2. 
NFAT and AP-1 family cooperatively 
Mechanisms of transcriptional regulation cannot be characterized in a single way.  The 
same concept applies to transcriptions factors.  By itself, no one-factor has the ability to regulate 
the vast information found within the genome.  NFAT and cJun are two transcription factors that 
have been characterized to regulate genes in their own independent manner.   NFAT and cJun, 
however, have been characterized to work in a cooperative manner, for example in the proximal 
promoter region of the IL-2 gene.  The binding of NFAT and cJun to composite sites proximal to 
the IL-2 transcription start site 
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Figure 4:  NFAT structure.  A) NFATc1 and NFATc2 both contain a NHR domain for binding 
calcineurin as well as a rel-like DNA binding domain.  B) Shows the interaction between NFAT 
and AP-1 in their tertiary structures. Macian, F., Lopez-Rodriguez, C. & Rao, a. Partners in 
transcription: NFAT and AP-1. Oncogene 20, 2476–89 (2001).  
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constitute a powerful method of transcriptional regulation50 (Figure 4B).  Our lab is interested in 
exploring other potential areas of biology that may use cooperative NFAT and cJun 
activation.  Specifically we are interested in this cooperative effect in mammary duct carcinoma 
upon exposure to the carcinogen cadmium chloride.  This thesis focuses on the effect of 
cadmium chloride on transcription as well as NFAT and cJun binding proximal to upregulated 
genes in mammary duct carcinoma cells.  
The role of environmental carcinogens in controlling NFAT and cJun activity 
A recent study done by the American Cancer Society revealed that 23% of all deaths in 
America in 2014 were attributed some form of cancer26. This ranks cancer as the second leading 
cause of death among the American population.  Understanding the fundamentals of this disease 
will help with the development of new treatments to lower this statistic and benefit those affected 
by cancer.  Cancer is not easily treated.  There is no foreign pathogen to be killed as seen in 
bacterial or viral infections. Rather, cells that the human immune system recognizes as self begin 
to demonstrate hallmark characteristics of cancer.  Two of these hallmarks are uncharacteristic 
differentiation and loss of replication regulation.  Cancerous cells lose the ability to communicate 
with other cells in proximity and differentiate independent of tissue type needs.  Also, cancerous 
cells lose their ability to self regulate cellular replication leading to characteristic 
tumors27.  Although predispositions such as BRCA-1 mutations can cause increased risk of 
cancer it is ultimately environmental factors known as carcinogens that lead to cancer 
onset28,29.  In order to provide better preventative health information to the population at large, 
environmental carcinogens need to be studied in depth to understand their mechanisms of action.  
Heavy metals are environmental carcinogens that are present near mining sites and in 
water runoffs potentially contaminating drinking water30.  Not only is there potential for water 
contamination, but also heavy metals have been seen to collect in tissues of many animals that 
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we eat, namely fish31.  Heavy metals are known carcinogens and have been shown to induce 
carcinomas in animal models and one hypothesis is that these small molecules mimic that of 
calcium and interrupt proper signaling within cells32,33.  Of these heavy metals, cadmium has 
been shown in increase the levels of cytosolic calcium35,36. Based on the mechanism by which 
NFAT is regulated it could be assumed that these heavy metals would activate it.  As well 
cadmium has been shown to activate the MAPK pathway in prostate cancer and increased 
activated cJun was observed32,37.  
Previously, this lab has shown that cytosolic calcium levels within MDA-MB-231 cells 
oscillate when stimulated with cadmium chloride.  As well, artificial increases in cytosolic 
calcium using PMA and ionomycin lead to NFAT localization to the nucleus in MDA-MB-231 
cells38.  These data lead us to wonder what affects cadmium chloride has on transcription levels 
of genes known to play a role in progression and invasion of mammary duct carcinoma.   More 
specifically we wanted to study the effects of cadmium on carcinoma related genes that are also 
regulated by NFAT or cJun.  
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Results: 
Cadmium titration affects some nascent transcripts in MDA-MB-231 Cells. 
        To explore nascent transcription effects of cadmium chloride, we selected five genes 
whose upregulation is associated with mammary duct carcinoma: CD4439, FasL40 , MMP-141, IL-
842, and ENPP-2 (autotaxin)43. To qualitatively determine the nascent expression patterns, we 
titrated in cadmium chloride from 1 to 25 micromolar.  PMA+ionomycin and no treatment were 
used as positive and negative controls, respectively.  Cells were exposed to each treatment for 6 
hours based on immunomicroscopy data showing full NFAT localization to the nucleus 7 hours 
after cytosolic calcium efflux38.   cDNA libraries of each of these samples where subject to RT-
PCR using primers that spanned intron-exon junctions.  The reason for use of intron-exon 
junction primers was to capture a snapshot of transcripts newly transcribed upon cadmium 
exposure.  This method, in theory, would omit detection of any mature RNA products.  Detection 
of these nascent RNAs would give us better insight into the effect cadmium has on 
transcription.  The results (Figure 5) showed that MMP-1, a matrix metalloproteinase, appeared 
to be upregulated up to concentrations of 25 micromolar cadmium chloride.  This finding would 
be consistent with research suggesting inhibition of MMP-1 leads to lower rate of metastasis and 
better prognosis in mammary duct carcinomas41.  We also found that ENPP-2 was upregulated 
upon titration of cadmium chloride.  Signals from IL-8 and FasL seemed to be less prominent 
than those from ENPP-2 and MMP-1, but their transcription did seem to respond to exposure to 
PMA+ionomycin.  Finally, CD44 failed to show much of a signal and transcription appears to 
remain constant throughout the titration.  
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Figure 5: Cadmium gel titration.  MDA-MB-231 cells were exposed to increasing concentrations 
of cadmium chloride form 1-25 micromolar for 6 hours.  RNA was isolated and turned into 
cDNA through reverse transcription.  Gene specific primers and PCR amplification was used for 
detection.  Gel was 1.8% agrose.  GAPDH –RT contained no reverse transcriptase.   
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The time course of the transcriptional response to cadmium in MDA-MB-231 Cells. 
It is clear that cadmium caused increases in transcription for some nascent transcripts, 
based on a single time point of treatment.  We were curious how varying exposure time would 
affect transcription from these genes.  We wanted to identify the best time point at which to 
expose cells for chromatin immune-precipitation.  In order to do this, we moved to a more 
quantitative method for determining transcript production through qualitative RT-PCR.  Based 
off the information provided from the previous RT-PCR experiment, we exposed our cells to 25 
micromolar cadmium chloride over various time intervals ranging from 2-12 hours.  cDNA 
libraries were created for these samples and analyzed via qPCR.  In order to create these data, Ct 
values for each biological and technical replicate were averaged together to minimize 
variations.  Ct values were calculated into delta delta Ct by finding the difference between the 
target gene untreated minus the reference gene untreated and the target gene treated minus the 
reference gene treated.  The reference gene used here was GAPDH.  Fold change was finally 
calculated by raising 2 to the delta delta Ct value 
        MMP-1 shows a variety of expression levels at the different time points, all of which are 
much greater than that observed in the absence of cadmium.  MMP-1 had an average increase of 
almost 37 fold and peaked at 60 at 6 hours.  The peak around 6 hours would explain the large 
increase in band intensity that we saw in the previous RT-PCR experiments (Figure 6B).  IL-8 
and ENPP-2 had interestingly opposite correlations from each other.  IL-8 showed a very large 
transcriptional induction that rapidly tapered off as the experiment progress out to 12 hours 
(Figure 6C&D).   By contrast, the ENPP-2 nascent transcripts seemed to gradually increase 
through the experiment peaking around a 25-fold increase at  
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Figure 6: Time course qPCR.  MDA-MB-231 cells were exposed to 25 micromolar CdCl2 over a variety 
of time periods.  RNA was isolated and reverse transcription used to make cDNA libraries.  cDNA 
libraries were subject to qPCR and fold change was calculated from Ct values.   
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12 hours.  Fold changes in FasL seemed to be decreased over the entire course of the 
experiment.  We were optimistic from the data collected through RT-PCR that we would find 
more interesting data, but these data suggest that FasL transcription is not induced from exposure 
to cadmium chloride (Figure 6A).  These data allowed us to monitor transcription over a large 
window of time and quantify the change in nascent transcription.  These data also suggest that 
genes associated with mammary duct carcinoma seem to have notable fold increases in 
transcription when cells are exposed to cadmium chloride.  
NFAT and cJun bind proximal promoter elements after cadmium exposure in MDA-MB-231 
Cells and SKBR-3 Cells. 
        Although cadmium exposure appears to induce transcription of genes documented to be 
upregulated in mammary duct carcinoma the mechanism of their control is 
unknown.  Documented increases in cJun and NFAT activity upon cadmium exposure lead us to 
question if cadmium could cause binding of these two factors to proximal promoter elements in 
the genes identified above.  To do this we performed chromatin immuno-precipitation (ChIP) on 
cells that had been exposed to cadmium for 6 hours along with positive and negative controls, 
PMA+ionomycin and no treatment, respectively.  ChIP assays were performed with a NFAT 
antibody, cJun antibody, or no antibody. DNA recovered was analyzed with qPCR using primers 
designed to flank known and potential NFAT and cJun binding sites in the genes of 
interest.  Data are represented as percent of input pulled down during precipitation (%IP). 
        At this point, we decided to broaden our scope of cells lines and include another 
mammary duct carcinoma line SKBR-3.  In both MDA-MB-231 as well as SKBR-3 cell  
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Figure 7: IL-2, MMP-1, ENPP-2 ChIP data. MDA-MB-231 and SKBR-3 cells were exposed to 25 uM 
CdCl2 for 6 hours and immune precipitated with NFAT and cJun antibodies.  Primers flanking potential 
proximal promoter NFAT and cJun binding sites were used to detect %IP.   
0 
0.02 
0.04 
0.06 
0.08 
0.1 
0.12 
0.14 
0.16 
Control Cadmium 
Chloride 
PMA/Iono 
%
IP
 
NFATc2 & cJun Enrichment in 
ENPP-2 Proximal Promoter of 
MDA-MB-231 Cells 
NFAT cJun No AB 
0	  
0.02	  
0.04	  
0.06	  
0.08	  
0.1	  
0.12	  
0.14	  
0.16	  
Control Cadmium 
Chloride 
PMA/Iono 
%
IP
 
NFATc2 & cJun Enrichment in 
MMP-1 Proximal Promoter of 
MDA-MB-231 Cells 
NFAT cJun No AB 
0 
0.02 
0.04 
0.06 
0.08 
0.1 
0.12 
0.14 
0.16 
Control Cadmium 
Chloride 
PMA/Iono 
%
IP
 
NFATc2 & cJun Enrichment in IL-2 
Proximal Promoter of MDA-MB-231 
Cells 
NFAT cJun No AB 
0 
0.02 
0.04 
0.06 
0.08 
0.1 
0.12 
0.14 
0.16 
Control Cadmium 
Chloride 
PMA/Iono 
%
IP
 
NFATc2 & cJun Enrichment in 
ENPP-2 Proximal Promoter of 
SKBR-3 Cells 
NFAT cJun No AB 
0	  
0.02	  
0.04	  
0.06	  
0.08	  
0.1	  
0.12	  
0.14	  
0.16	  
Control Cadmium 
Chloride 
PMA/Iono 
%
IP
 
NFATc2 & cJun Enrichment in 
MMP-1 Proximal Promoter of 
SKBR-3 Cells 
NFAT cJun No AB 
0	  
0.02	  
0.04	  
0.06	  
0.08	  
0.1	  
0.12	  
0.14	  
0.16	  
Control Cadmium 
Chloride 
PMA/Iono 
%
IP
 
NFATc2 & cJun Enrichment  in IL-2 
Proximal Promoter of SKBR-3 Cells 
NFAT cJun No AB 
A)	   	   	   	   	   	   B)	  	  	  	  	  	  	  	  	  	  	  	  	  	  
C)	   	   	   	   	   	   D)	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
E)	   	   	   	   	   	   F)	  
	   23	  
lines we used IL-2 as an indicator that the ChIP experiment was working correctly.  NFAT was 
originally characterized in IL-2 as a transcription factor needed for T cell 
differentiation.   Recently this lab has also done studies showing that NFAT and homodimers of 
cJun work as cooperative transcription factors in the regulation of IL-250.  The signal received 
from ChIP-qPCR shows enrichment of both cJun and NFAT at a sight previously characterized 
as one that cooperatively binds NFAT and cJun (Figure 7C&F).  
        Analysis of ENPP-2 and MMP-1 promoter regions showed binding motifs for both 
NFAT and cJun within close proximity of each other and within a few hundred bases of the 
transcription start site51,52 ChIP signal from these sites shows an enrichment of NFAT and cJun in 
ENPP-2 when treated with PMA+ionomycin, but not with exposure to cadmium (Figure 
7A&D).  Contrary to this, MMP-1 ChIP signal favors NFAT and cJun enrichment in cadmium 
exposed cells over PMA+ionomycin treated cells(Figure 7B&E).  .    
Identification of other genes upregulated by cadmium that bind NFAT and cJun in MDA-MB-
231 cells. 
Attempting to identify target genes for testing through individual papers documenting a 
genes relation to mammary duct carcinoma as well as those documenting NFAT or cJun control 
was tedious.  At this point we came up with the idea to use current ChIP-seq data for binding 
sites of cJun in HeLa cells53.  This data was extracted to an excel document and paired down to 
only genes with cJun binding sites within -300 and +100 of the transcription start site.  The set of 
genes produced was then cross referenced with a paper depicting gene expression profiles in 
breast cancer patients with poor prognosis signatures.  Those that had a cJun-binding site in the -
300 and +100 range and were upregulated in patients with poor prognosis were selected.  Finally, 
the selected genes were put into Snap Gene Viewer to identify genes that had a NFAT binding 
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E)	   	   	   	   	   	   Figure 8: Alternate gene qPCR and ChIP data. MDA-MB-231 cells were exposed to 25 uM 
CdCl2 for 6 hours and immune precipitated with 
NFAT and cJun antibodies.  Primers flanking 
potential proximal promoter NFAT and cJun 
binding sites were used to detect %IP.  Time 
course qPCR.  MDA-MB-231 cells were exposed 
to 25 micromolar CdCl2 over a variety of time 
periods.  RNA was isolated and reverse 
transcription used to make cDNA libraries.  
cDNA libraries were subject to qPCR and fold 
change was calculated from Ct values.   
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Motif proximal to a cJun binding site.  These genes were analyzed for expression changes upon 
cadmium exposure as well as binding of both NFAT and cJun in their proximal promoters.   
        The RAB11 and CDK2N genes were identified as potential targets.  Again cells were 
exposed to a time course of 25 micromolar cadmium chloride from 2 to 12 hours and total RNA 
isolated.   CDK2N showed strong induction over the untreated control after the 4-hour 
mark.  Induction was variable over the 4-12 hour period, but exceeded 20 fold at all time points 
(Figure 8D).  RAB11 showed similar transcription characteristics to IL-8.  A signal is seen at 2 
hours, but dampens out over time (Figure 8E).  Nonetheless, RAB11 appears to be upregulated 
as well upon cadmium exposure.  
        The RAB11 and CDK2N proximal promoter binding of NFAT and cJun was studied 
next.  ChIP was used again with qPCR and primers flanking the previously analyzed NFAT and 
cJun binding sites.   The data revealed that the proximal promoter for RAB11 showed much 
better enrichment of NFAT and cJun after cadmium exposure (Figure 8A).  On the contrary, 
CDK2N had higher enrichment of NFAT and cJun in the control sample indicating that NFAT 
and cJun binding to this region was not induced by cadmium exposure (Figure 8B).  
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Discussion 
Cadmium is known as a carcinogen that has induced cancer in animal models.  However, 
the mechanisms through which cadmium induces cancer need to be studied.  Specifically, we 
looked at a few of the multitude of genes that are involved in cancer in order to see how 
cadmium affects their transcription within a mammary duct carcinoma cell line.  To do this, we 
used RT-PCR coupled with titration of cadmium chloride to show that cadmium is in fact 
causing induction.  Secondly, qRT-PCR was used to determine quantitative expression changes 
with in our cell line.  
The set of genes we investigated was selected based off previous research that has shown 
these genes are also under control of transcription factors NFAT or cJun44-48.   A hypothesized 
model is that oscillation in calcium signals, previously demonstrated in this lab, could activate 
NFAT and cJun and yield stronger transcriptional induction over steady state levels of 
calcium38.  Increased oscillatory induction of NFAT responsive genes has been observed in T 
cells24,25.  We believe that these findings along with others that support activation of cJun through 
the MAPK pathway could be a possible mechanism for up regulation of the genes studied above.  
Our data show increased transcription of genes after treatment with cadmium, which is 
the framework for future experiments.  Strong transcriptional induction is the end result of 
upregulation via activating transcription factors such as NFAT and cJun.  Previous information 
on the cooperative binding of NFAT and cJun to the IL-2 promoter suggests that these two 
transcription factors could synergize to regulate transcription of specific genes.  These 
experiments do not prove cooperatively, however increased nascent mRNA products as well as 
enrichment of both NFAT and cJun at proximal promoters encourages further conclusive 
experiments for cooperative binding of NFAT and cJun. To better determine if these genes are 
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under cooperative control some sort of knock out must be done for each and the ChIP as well as 
qRT-PCR data compared to control cells before and after cadmium treatment.  On a genome 
wide scale, ChIP-seq as well as RNA-seq data could be collected in order to determine the effect 
of cadmium chloride genome wide.  Regardless, we are enthusiastic about the observed cadmium 
induced increase in these genes coupled with NFAT and cJun binding to proximal promoters. 
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Materials and Methods 
Chemicals and reagents 
Cadmium chloride was dissolved in ultra-pure water to a stock concentration of 1 M and 
stored at -20°C for up to one month. 
Cell culture 
Human mammary adenocarcinoma cells (MDA-MB-231) were cultured in Libovitz’s L-
15 medium supplemented with 10% (v/v) fetal bovine serum, 2 mM L-glutamine, 100 U/mL 
penicillin and 100 µg/mL streptomycin.  Cells were maintained at 37 °C and 0% CO2 in a humid 
incubator; they were trypsinized with 0.25% trypsin and sub-cultured roughly every four days. 
Cells were treated with CdCl2 by exchanging medium with fresh medium containing various 
concentrations of CdCl2.  In all cases, the amount of DMSO in the medium never exceeded 0.3% 
(v/v).   
Human mammary adenocarcinoma cells (SKBR-3) were cultured in DMEM medium 
supplemented with 10% (v/v) fetal bovine serum, 2 mM L glutamine, 100 U/mL penicillin and 
100 µg/mL streptomycin.  Cells were maintained at 37 °C and 5% CO2 in a humid incubator; 
they were trypsinized with 0.25% trypsin and sub-cultured roughly every four days. Cells were 
treated with CdCl2 by exchanging medium with fresh medium containing various concentrations 
of CdCl2.  In all cases, the amount of DMSO in the medium never exceeded 0.3% (v/v).   
mRNA extraction 
MDA-MB-231, and SKBR-3 cells at 70% confluence were treated for 6 to 12 hours with 
CdCl2. Post treatment, cells were scraped from the plate and spun at 1100x g for 5 minutes. The 
supernatant was discarded and the cells were suspended in 200 µL TRIzol (Life Technologies) 
followed by incubation for 5 minutes. 40 µL of chloroform were added and, after 15 seconds of 
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gentle agitation, the solution was centrifuged at 16,000x g for 15 minutes. The aqueous phase 
was removed and the RNA was precipitated with 100 µL isopropanol. The collected RNA was 
pelleted, and washed with 75% ethanol before suspension in 1x RQ-1 DNase buffer. Samples 
were treated with 1 unit of RQ-1 DNase (Promega) for 20 minutes at 37 °C, followed by the 
addition of 1 µL DNase stop solution and a 10 minute incubation at 65 °C.  cDNA was 
synthesized from the extracted RNA using 1 unit of Multiscribe RT, 10 µM random hexamer 
primers, and 2 mM dNTPs in 1x RT buffer (Promega). Samples were incubated at 25 °C for 5 
minutes, then at 37 °C for 1 hour before ramping up to 65 °C to inactivate the 
Multiscribe.  Individual mRNA products were detected using custom primers in 30-34 cycles of 
PCR. PCR products were resolved on a 1.8% agarose gel and detected using fluorescence 
scanning (Typhoon). 
As well, qPCR was conducted on RNA extractions.  Reactions were set up using Life 
Technologies 96 well plates.  Master mixes for each primer set were made with the following for 
one reaction; 11 µL SYBR green (Life Technologies), 0.66 µL forward primer, 0.66 µL reverse 
primer, 5.68 µL water, 4 µL cDNA from RNA extraction.  18 µL of master mix with out cDNA 
was pipetted into 0.65 µL tubes and 4 µL of cDNA added for a total volume of 22 µL.  From 
these 22 µL tubes 10 µL was pipetted into adjacent wells in the plate for technical duplicates.  
Samples were analyzed in Life Technologies StepOnePlusTM Real-Time PCR System.   
Chromatin Immuno-Precipitation 
Human mammary adenocarcinoma cells (MDA-MB-231 and SKBR-3) were grown to 
confluence in T-175 adherent cell flasks.  The control group, cadmium chloride, and the 
PMA+ionomycin group were each assigned one T-175.  The PMA+ionomycin group and the 
cadmium chloride were exposed for 9 hours.  Post exposure cross-linking of protein to DNA was 
achieved by adding 810 uL of 37% formaldehyde for a final concentration of 1% to each flask 
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and placed on a shaker for 8 minutes.  1.5 mL of 2.5M glycine was added to give a final 
concentration of 0.125M and incubated for 5 minutes in order to stop the cross linking 
reaction.  Media was aspirated and the cells were washed twice with PBS.  10 mL of cold PBS 
was added to each flask and cells were scraped and transferred to 15 mL TPX conical.  50 uL of 
each TPX conical was saved in order to determine cell count.  
In order to isolate the nuclei of the cells each TPX conical was spun down at 1-2K RPM 
at 4 °C for 5 minutes.  Cells where then washed with cold PBS.  NRO buffer was added in a 
volume of 80 uL per million cells counted previously and incubated for 5 minutes.  Samples 
where then spun at 3K at 4 °C for 5 minutes and the supernatant aspirated.  Pellets were washed 
with the same volume of NRO buffer, and pellets were then frozen in liquid nitrogen. 
 To shear the chromatin for immunoprecipitation, pellets were resuspended in lysis buffer 
at a volume of 30 uL per million cells and incubated on a rocker for 10 minutes a 4 °C.  Dilution 
buffer was then added in a 2:1 ratio.  Chromatin were sheared via sonication in a Diagenode 
bioruptor with 30 seconds on and 30 second off for 25 minutes for the MDA-MB-231 cell line 
and 35 minutes for the SKBR3 cell line.  After shearing samples where spun at 14K at 4 °C for 
10 minutes and supernatant removed into new tubes which were stored at -80 °C. 
Immunoprecipitation (IP) started with pre-clearing the sonicated chromatin with beads in order 
to minimize non-specific pull down.  This was done by pipetting 100 ul of each of control, 
cadmium chloride and ionomycin/PMA chromatin into eppendorf tubes corresponding to: Input, 
NFATc2, c-Jun, and minus antibody for a total of 12 tubes.  Beads were equilibrated by washing 
3 times in 10 column volumes of IP buffer.  15 uL equilibrated packed bead volume was pipetted 
into each tube and incubated for 2 hours at 4 °C.  Beads were spun down, and the supernatant 
was pipetted into new tubes. Inputs were set aside for later precipitation.  IP against the protein 
of interest was done by adding 4ug of NFAT or cJun antibody (NFAT: SC7296 cJun: SC1694) 
	   31	  
to 100 ul precleared chromatin samples diluted to 300 ul with IP buffer and then placed on a 
rocker overnight at 4 °C.  Beads were blocked by equilibration in IP buffer and then left 
overnight at 4 °C with 0.4 mg/ml yeast RNA and 0.5 mg/ml BSA.  Preblocked beads were then 
washed twice with IP buffer and 20 ul packed bead volume was added to the antibody chromatin 
samples.  Samples were rocked at 4 °C for 2 hours and then washed with low salt, high salt, 
lithium chloride, and TE buffers (spin, aspirate, add new buffer).  Cross linked protein to DNA 
was then reverses by adding 250 ul of elution buffer and incubated for 1 hour at 37 °C.  Samples 
and input sodium chloride concentration was raised to 200 mM and incubated at 65 °C for 12 
hours.  Inputs and samples where then proteinase K treated at 55 °C for 1 hour.  Beads were spun 
and supernatants removed and phenol chloroform extracted.  Extractions where then ethanol 
precipitated with 1/10 volume 3 M sodium acetate, 5 ug glycogen blue, and 2.5 volumes of 
100% ethanol.  Pellets were washed with 70% ethanol and dried in speed vac.  Sample pellets 
were resuspended in 40 uL of water and inputs in 100 uL of water. 
qPCR of elutes from precipitation was done to detect %IP. Reactions were set up using Life 
Technologies 96 well plates.  Master mixes for each primer set were made with the following for 
one reaction; 11 µL SYBR green (Life Technologies), 0.66 µL forward primer, 0.66 µL reverse 
primer, 5.68 µL water, 4 µL sample from elutes.  18 µL of master mix with out cDNA was 
pipetted into 0.65 µL tubes and 4 µL of cDNA added for a total volume of 22 µL.  From these 22 
µL tubes 10 µL was pipetted into adjacent wells in the plate for technical duplicates.  Samples 
were analyzed in Life Technologies StepOnePlusTM Real-Time PCR System.  Relative standard 
curves were determined by diluting input samples from one to one thousand and quantities of 
elute samples determine form the standard curve in Life Technologies software.  
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